Mycophenolate mofetil
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Mycophenolate mofetil is a generic prescription drug available as 250 mg oral capsules. It acts as an antimetabolite immunosuppressant, often used to prevent organ rejection in transplant patients. Manufactured by AvKARE under ANDA090055, it comes in bottles of 100 or 500 capsules, with marketing starting May 25, 2025. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Mycophenolate mofetil
Access the FDA dataset for Mycophenolate mofetil — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025